These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28837031)

  • 1. Can ovarian double-stimulation in the same menstrual cycle improve IVF outcomes?
    Cardoso MCA; Evangelista A; Sartório C; Vaz G; Werneck CLV; Guimarães FM; Sá PG; Erthal MC
    JBRA Assist Reprod; 2017 Sep; 21(3):217-221. PubMed ID: 28837031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
    Drakopoulos P; Blockeel C; Stoop D; Camus M; de Vos M; Tournaye H; Polyzos NP
    Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
    Hohmann FP; Macklon NS; Fauser BC
    J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of starting ovarian stimulation on day 2 versus day 15 of the menstrual cycle in the same oocyte donor and pregnancy rates among the corresponding recipients of vitrified oocytes.
    Martínez F; Clua E; Devesa M; Rodríguez I; Arroyo G; González C; Solé M; Tur R; Coroleu B; Barri PN
    Fertil Steril; 2014 Nov; 102(5):1307-11. PubMed ID: 25154677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follicular versus luteal phase ovarian stimulation during the same menstrual cycle (DuoStim) in a reduced ovarian reserve population results in a similar euploid blastocyst formation rate: new insight in ovarian reserve exploitation.
    Ubaldi FM; Capalbo A; Vaiarelli A; Cimadomo D; Colamaria S; Alviggi C; Trabucco E; Venturella R; Vajta G; Rienzi L
    Fertil Steril; 2016 Jun; 105(6):1488-1495.e1. PubMed ID: 27020168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of intracytoplasmic sperm injection in non-male factor infertility in advanced maternal age.
    Tannus S; Son WY; Gilman A; Younes G; Shavit T; Dahan MH
    Hum Reprod; 2017 Jan; 32(1):119-124. PubMed ID: 27852688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study.
    Buendgen NK; Schultze-Mosgau A; Cordes T; Diedrich K; Griesinger G
    Arch Gynecol Obstet; 2013 Oct; 288(4):901-4. PubMed ID: 23545834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of triploidy incidence on clinical outcomes for IVF-ET cycles in different ovarian stimulation protocols.
    Li M; Xue X; Zhang S; Li W; Zhao X; Ren W; Shi J
    Gynecol Endocrinol; 2015 Oct; 31(10):769-73. PubMed ID: 26220642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between growth dynamics, morphological parameters, the chromosomal status of the blastocysts, and clinical outcomes in IVF PGS cycles with single embryo transfer.
    Barash OO; Ivani KA; Willman SP; Rosenbluth EM; Wachs DS; Hinckley MD; Pittenger Reid S; Weckstein LN
    J Assist Reprod Genet; 2017 Aug; 34(8):1007-1016. PubMed ID: 28560610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.
    Weitzman VN; Engmann L; DiLuigi A; Maier D; Nulsen J; Benadiva C
    Fertil Steril; 2009 Jul; 92(1):226-30. PubMed ID: 18675961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luteal-phase ovarian stimulation increases the number of mature oocytes in older women with severe diminished ovarian reserve.
    Rashtian J; Zhang J
    Syst Biol Reprod Med; 2018 Jun; 64(3):216-219. PubMed ID: 29564925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection.
    Qin N; Chen Q; Hong Q; Cai R; Gao H; Wang Y; Sun L; Zhang S; Guo H; Fu Y; Ai A; Tian H; Lyu Q; Daya S; Kuang Y
    Fertil Steril; 2016 Aug; 106(2):334-341.e1. PubMed ID: 27114329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longer ovarian stimulation reduces embryo number and clinical pregnancy rate in long GnRH agonist cycles.
    Dunne C; Lawrence C; Albert A; Havelock JC
    Minerva Ginecol; 2017 Apr; 69(2):135-140. PubMed ID: 27270672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined?
    Shavit T; Ellenbogen A; Michaeli M; Kartchovsky E; Ruzov O; Shalom-Paz E
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():46-50. PubMed ID: 24965979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double stimulation in the same ovarian cycle (DuoStim) is an intriguing strategy to improve oocyte yield and the number of competent embryos in a short timeframe.
    Vaiarelli A; Cimadomo D; Argento C; Ubaldi N; Trabucco E; Drakopoulos P; Venturella R; Conforti A; Alviggi C; Rienzi L; Ubaldi FM
    Minerva Ginecol; 2019 Oct; 71(5):372-376. PubMed ID: 30848112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High gonadotropin dosage does not affect euploidy and pregnancy rates in IVF PGS cycles with single embryo transfer.
    Barash OO; Hinckley MD; Rosenbluth EM; Ivani KA; Weckstein LN
    Hum Reprod; 2017 Nov; 32(11):2209-2217. PubMed ID: 29040519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Luteal-phase ovarian stimulation vs conventional ovarian stimulation in patients with normal ovarian reserve treated for IVF: a large retrospective cohort study.
    Wang N; Wang Y; Chen Q; Dong J; Tian H; Fu Y; Ai A; Lyu Q; Kuang Y
    Clin Endocrinol (Oxf); 2016 May; 84(5):720-8. PubMed ID: 26603821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative prospective study of 2 ovarian stimulation protocols in poor responders: effect on implantation rate and ongoing pregnancy.
    Merviel P; Cabry-Goubet R; Lourdel E; Devaux A; Belhadri-Mansouri N; Copin H; Benkhalifa M
    Reprod Health; 2015 May; 12():52. PubMed ID: 26025412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
    Jiang S; Kuang Y
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of estradiol/follicle and estradiol/oocyte ratios on the outcome of controlled ovarian stimulation for in vitro fertilization.
    Orvieto R; Zohav E; Scharf S; Rabinson J; Meltcer S; Anteby EY; Homburg R
    Gynecol Endocrinol; 2007 Feb; 23(2):72-5. PubMed ID: 17454155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.